Gain Therapeutics, Inc. (GANX)

Latest Insider Confidence Score

2025Q4

50.1
Bullish

Company insider confidence (by quarter)

2021Q1 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Islam Khalid Chair 880,784 Aug 12, 2024
Bellotto Manolo 123,309 Mar 29, 2021
Fuggetta Gianluca 50,000 Mar 25, 2024
Ballantyne Charles Evan 50,000 Apr 12, 2023
Calabrese Salvatore CFO 25,000 Mar 27, 2023

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 24, 2025 Jun 25, 2025 Islam Khalid Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 25, 2025 Nicaise Claude Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 25, 2025 Riley Jeffrey Scott Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 25, 2025 RICHMAN ERIC I Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 25, 2025 HASLER HANS PETER Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 25, 2025 GOLDSTEIN DOV A MD Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 25, 2025 Melincoff Gwen A Director Neutral 52.5 - 0.00% -
Mar 20, 2025 Mar 21, 2025 Fuggetta Gianluca Officer Neutral 52.5 - 0.00% -
Mar 20, 2025 Mar 21, 2025 Mack Gene CEO Neutral 52.5 - 0.00% -
Jan 6, 2025 Jan 7, 2025 Mack Gene CEO Neutral 52.5 - 0.00% -
Aug 9, 2024 Aug 12, 2024 Mack Gene CEO Buy 91.3 +14,400 100.00% $14.5K
Aug 9, 2024 Aug 12, 2024 Islam Khalid Chair Buy 86.3 +50,000 5.68% $49.9K
Jul 1, 2024 Jul 1, 2024 RICHMAN ERIC I Director Buy 86.3 +17,000 5.91% $20.7K
Jun 24, 2024 Jun 26, 2024 Islam Khalid Director Neutral 52.5 - 0.00% -
Jun 24, 2024 Jun 26, 2024 Melincoff Gwen A Director Neutral 52.5 - 0.00% -
Jun 24, 2024 Jun 26, 2024 HASLER HANS PETER Director Neutral 52.5 - 0.00% -
Jun 24, 2024 Jun 26, 2024 Nicaise Claude Director Neutral 52.5 - 0.00% -
Jun 24, 2024 Jun 26, 2024 RICHMAN ERIC I Director Neutral 52.5 - 0.00% -
Jun 24, 2024 Jun 26, 2024 GOLDSTEIN DOV A MD Director Neutral 52.5 - 0.00% -
Jun 24, 2024 Jun 26, 2024 Riley Jeffrey Scott Director Neutral 52.5 - 0.00% -
Apr 8, 2024 Apr 8, 2024 Mack Gene CFO Neutral 52.5 - 0.00% -
Apr 8, 2024 Mack Gene CFO Neutral 52.5 - 0.00% -
Mar 28, 2024 Apr 1, 2024 Riley Jeffrey Scott Director Buy 95.0 +30,000 100.00% $115.8K
Mar 26, 2024 Mar 28, 2024 Alder Matthias CEO Sell 46.3 -6,085 -22.35% $24.7K
Mar 21, 2024 Mar 25, 2024 Fuggetta Gianluca Officer Neutral 52.5 - 0.00% -
Mar 21, 2024 Mar 25, 2024 Alder Matthias CEO Neutral 52.5 - 0.00% -
Dec 20, 2023 Dec 22, 2023 Alder Matthias CEO Sell 27.5 -206 -3.75% $506.8
Dec 7, 2023 Dec 14, 2023 Alder Matthias CEO Sell 47.5 -1,820 -27.27% $4.6K
Oct 1, 2023 Oct 3, 2023 Alder Matthias CEO Neutral 52.5 - 0.00% -
Sep 20, 2023 Sep 22, 2023 RICHMAN ERIC I Director Neutral 52.5 - 0.00% -
Sep 20, 2023 Sep 22, 2023 Alder Matthias CEO Neutral 52.5 - 0.00% -
Jul 1, 2023 Jul 5, 2023 Alder Matthias CEO Neutral 52.5 - 0.00% -
Jun 23, 2023 Jun 26, 2023 Islam Khalid Director Neutral 52.5 - 0.00% -
Jun 23, 2023 Jun 26, 2023 Riley Jeffrey Scott Director Neutral 52.5 - 0.00% -
Jun 23, 2023 Jun 26, 2023 GOLDSTEIN DOV A MD Director Neutral 52.5 - 0.00% -
Jun 23, 2023 Jun 26, 2023 Melincoff Gwen A Director Neutral 52.5 - 0.00% -
Jun 23, 2023 Jun 26, 2023 Nicaise Claude Director Neutral 52.5 - 0.00% -
Jun 23, 2023 Jun 26, 2023 HASLER HANS PETER Director Neutral 52.5 - 0.00% -
Apr 10, 2023 Apr 12, 2023 Ballantyne Charles Evan CFO Neutral 52.5 - 0.00% -
Apr 12, 2023 Ballantyne Charles Evan CFO Neutral 52.5 - 0.00% -
Mar 23, 2023 Mar 27, 2023 Calabrese Salvatore CFO Neutral 52.5 - 0.00% -
Mar 23, 2023 Mar 27, 2023 Fuggetta Gianluca Principal Accounting Officer Neutral 52.5 - 0.00% -
Mar 23, 2023 Mar 27, 2023 Alder Matthias CEO Neutral 52.5 - 0.00% -
Dec 21, 2022 Fuggetta Gianluca Principal Accounting Officer Neutral 52.5 - 0.00% -
Sep 20, 2022 Sep 22, 2022 RICHMAN ERIC I Director Neutral 52.5 - 0.00% -
Sep 20, 2022 Sep 22, 2022 Islam Khalid Director Neutral 52.5 - 0.00% -
Sep 20, 2022 Sep 22, 2022 Riley Jeffrey Scott Director Neutral 52.5 - 0.00% -
Sep 20, 2022 Sep 22, 2022 GOLDSTEIN DOV A MD Director Neutral 52.5 - 0.00% -
Sep 20, 2022 Sep 22, 2022 Melincoff Gwen A Director Neutral 52.5 - 0.00% -
Sep 20, 2022 Sep 22, 2022 Nicaise Claude Director Neutral 52.5 - 0.00% -
Sep 20, 2022 Sep 22, 2022 HASLER HANS PETER Director Neutral 52.5 - 0.00% -
Sep 20, 2022 Sep 22, 2022 Alder Matthias COO Neutral 52.5 - 0.00% -
Jul 15, 2022 Jul 19, 2022 Calabrese Salvatore CFO Neutral 52.5 - 0.00% -
Jul 15, 2022 Jul 19, 2022 Alder Matthias COO Neutral 52.5 - 0.00% -
May 25, 2022 May 27, 2022 RICHMAN ERIC I CEO Buy 77.5 +2,482 1.08% $6.4K
May 19, 2022 May 23, 2022 RICHMAN ERIC I CEO Buy 83.8 +13,256 3.14% $37K
May 19, 2022 May 23, 2022 Calabrese Salvatore CFO Buy 90.0 +3,000 100.00% $8.1K
May 19, 2022 May 19, 2022 Calabrese Salvatore CFO Buy 40.0 - 0.00% $24.3M
Aug 16, 2021 Apr 21, 2022 RICHMAN ERIC I CEO Buy 78.8 +4,922 2.32% $38.7K
Apr 21, 2022 RICHMAN ERIC I CEO Neutral 52.5 - 0.00% -
Dec 23, 2021 Dec 28, 2021 Alder Matthias COO Neutral 52.5 - 0.00% -
Dec 28, 2021 Alder Matthias COO Neutral 52.5 - 0.00% -
Aug 16, 2021 Aug 17, 2021 RICHMAN ERIC I Director Neutral 52.5 - 0.00% -
Mar 29, 2021 Bellotto Manolo President Neutral 52.5 - 0.00% -
Mar 29, 2021 Calabrese Salvatore CFO Neutral 52.5 - 0.00% -
Mar 29, 2021 Riley Jeffrey Scott Director Neutral 52.5 - 0.00% -
Mar 29, 2021 HASLER HANS PETER Director Neutral 52.5 - 0.00% -
Mar 17, 2021 Melincoff Gwen A Director Neutral 52.5 - 0.00% -
Mar 17, 2021 Nicaise Claude Director Neutral 52.5 - 0.00% -
Mar 17, 2021 Islam Khalid Director Neutral 52.5 - 0.00% -
Mar 17, 2021 RICHMAN ERIC I CEO Neutral 52.5 - 0.00% -
Mar 17, 2021 GOLDSTEIN DOV A MD Director Neutral 52.5 - 0.00% -